S Katagiri, N Furuya, D Akahane, SG Chi… - OncoTargets and …, 2023 - Taylor & Francis
We performed sequential molecular analyses of a 75-year-old woman with de novo FLT3-
ITD positive acute myeloid leukemia (AML) who had received gilteritinib therapy for 43 …